Book of the month Science or bust
We have the paradox that people who are dependent on applied science for food, clothing, communication, and indeed their entire material life-style are willing to bring to their consideration of science a combination of ignorance and hostility which they would be ashamed to deploy in considering any other large area of human activity1.
In 1860s Paris, female fashion looked to the Empress Eugenie, the best dressed woman in Europe. She set the style for an evening gown with a vast crinoline bottom and a revealing top known as a decolletage a la baignoire. With a tightly laced corset, even small-breasted ladies could expose a satisfyingly large expanse of bosom, displayed to greatest effect from an opera box. Once in a while, a lady's exposure would get alarmingly out of control, whereupon her spouse rushed to shield her with his programme until decorum had been restored.
Over a century later, breasts were once again in fashion; corsetry was not. The answer for 970s women who perceived themselves 'underendowed' was provided by science. Breast implants became big business, for plastic surgeons, implant manufacturers, and ultimately lawyers. They also provided a telling lesson about the nature of evidence.
Dr Marcia Angell, Executive Editor of the New England Journal ofMedicine, found herself drawn to the breast implant story when that journal published papers on the subject in 1992 and 1994. The first article was by David Kessler, Commissioner of the US Food and Drug Administration, explaining why the FDA had just banned silicone-gel-filled implants on safety grounds. The second was a retrospective cohort study from the Mayo Clinic which did not show a link between implants and disease. Angell wrote accompanying editorials on both occasions and became 'hooked' by the subject. In Science on Trial2 she gives the reason for her fascination, as she uncovers a tale of greed; of the gulf between legal and scientific standards of evidence; and of the rejection of science by a public dependent on the technology it generates. Angell embarked on her book, which is written for a general audience, because the story 'illuminates important themes in American life', many of which have far wider implications.
Kessler's 1992 ban on silicone implants was taken in response to the lack of evidence concerning their safety. Implants had been marketed for about 30 years but under FDA purview only since 1976. In view of the long track record, implants were presumed to be reasonably safe, but in 1988 the FDA asked manufacturers for evidence of safety and effectiveness. That evidence was not forthcoming, at least not in a form that satisfied the FDA's advisory panel, and the ban was introduced (except for some research projects). Without acceptable safety data, the scales were tipped in favour of evidence of harm, which was nevertheless conspicuously absent. So what forced the FDA's hand?
Beginning in the 1960s, Angell notes that there were a few Japanese reports of connective tissue disease in women who had received injections of paraffin or silicone for breast augmentation. (This procedure, which produced appalling local complications, was originally adopted by Japanese prostitutes to satisfy the taste of American servicemen for large breasts, later spread to the USA, and subsequently stimulated the development of silicone implants.) The crunch came in 1982, with an Australian report of connective tissue disease in three women with silicone implants. Successful US lawsuits soon followed, beginning in 1984 with an award of US$ 2 million to a woman whose medical problems remain largely undefined but satisfied a jury none the less. By 1991 a San Francisco jury had awarded US$ 7.34 million to a woman with mixed connective tissue disease whose symptoms had antedated the implants. Media coverage was intense. In the eyes of the public, breast implants were harmful. And politicians were breathing down Kessler's neck. It is easy to see why, in Angell's view, Kessler's decision was influenced not merely by science (of which there was precious little) but by a heady mix of public opinion, politics, and the law.
Angell predicted in her 1992 editorial that the FDA ban, however it was cast, would be taken as proof that implants were highly dangerous. She was right. There was a frenzy of litigation, including a class action settlement that began to flounder almost as soon as it was put together. Lawyers, with slick advertising techniques, profited handsomely from contingency fees. Women rushed to have implants removed. And the mass media went wild, castigating big business for selling a dangerous product and the FDA for tardy decisions, and demanding to know why medical researchers could not provide the right answers. A few doctors meanwhile seemingly abandoned their scientific upbringing, joined forces with plaintiffs' attorneys, and produced expert evidence in court uninformed by anything resembling scientific rigour.
Whereas scientists have to provide the evidence on which their conclusions are based, expert witnesses, selected by contesting lawyers to give firm opinions, do not have to produce any evidence at all. Angell argues that the fundamental issue in both science and the courtroom should be the same-the quality of the evidence. Her solution is for judges to appoint expert witnesses (who could be Volume 90 Fe bru ary 1 9 9 7 recommended by reputable organizations) to interpret the evidence for the court and not to represent one or other side.
Few would challenge Angell's view that we ought to want to know the truth. But that depends on general acceptance of scientific research methods and unbiased interpretation of results. In late 1995, the American College of Rheumatology reviewed the accumulated evidence and concluded that 'silicone breast implants expose patients to no demonstrable additional risk of connective tissue disease or rheumatological disease'. Two weeks later, a jury in Reno, Nevada, awarded US$ 4.1 million compensation and US$ 10 million punitive damages to a plaintiff. The truth, even when it comes, may fall resoundingly flat. This book has a curious title. The first volume was written to commemorate the 150th anniversary of British psychiatry as an organized clinical group and one would have thought the 'aftermath' was only the 5 years between 1991 and 1996. In fact the contents suggest afterthought rather than aftermath, since they cover aspects of the 150 years ignored or only scantily addressed in the earlier volume. A historical review can illuminate in many ways: it can tell us that present problems are nothing new, set the past into order with the benefit of hindsight, and meld people with events to show we are instrumental in creating history as well as sometimes being passive spectators. This book does illuminate, but the overall effect is chiaroscuro with sharp contrasts between the chapters. This could be regarded as a consequence of editorial laxity but could equally be seen as a fair reflection of British psychiatry over the past 150 years, an eclectic mix of stunning insights and rigid prejudice, reasoned debate and wild polemic, and alternating liberal and oppressive treatment of the mentally ill.
All parts of British (and Irish) psychiatry are here-psychotherapy, mental handicap, the addictions, rehabilitation psychiatry, forensic psychiatry and biological psychiatry. This broad brush is extended to other disciplines within psychiatry, including mental health nursing, occupational therapy and psychology. Try as we may we cannot stop recapitulating history and it is fascinating to see how many burning issues of the past are no different from today. The decriminalisation of cannabis consumption was a lively subject for debate in the BMJ 100 years ago; the early phrenologists in Edinburgh constructed brain function in the same way as neuro-imaging scientists of today; and the violent controversy over the efficacy of psychoanalysis and psychotherapy of the 1970s and 1980s was encapsulated in miniature (and probably resolved more sensibly) in Maghull Hospital to the North of Liverpool during the First World War.
Unfortunately, this range perhaps goes too far at times (the history of British psychopharmacology deals predominantly with the subject since 1974) and it is difficult to get any sense of coherence from the book as a whole. It is really a historical memory bank which is helped by a good index covering people, events and subjects. The breadth of scholarship and research in this volume is impressive and some chapters are very good indeed. I particularly liked Andrew Scull's account of the career of Thomas Chivers Graves, a psychiatrist who rose to be head of the Royal Medico-Psychological Association and stuck throughout his life to the notion that all mental illness was due to 'autotoxicity' from infections; Henry Rollin's words on the ambivalent legal status of forensic psychiatrists in his contribution on the history of forensic psychiatry; and Peter Nolan's account of the history of mental health nursing in which years ago 'nursing effectiveness was judged by the state of the ward and not the state of the patients'.
The book also gives a good picture of the troughs of despond and heights of ecstasy at various times in the past 150 years. Many of us feel we are currently in one of our cyclical troughs but reading this book will convince that the cycle should continue and better times must lie ahead. The British (and the Irish) are a pragmatic race of psychiatrists, used to working against alien conditions and finding effective ways to move forward. For those who despair at the current state of psychiatry in some parts of these islands there is much to learn from these 600 pages.
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